KR101817514B1 - 헤스페레틴의 신규 용도 - Google Patents

헤스페레틴의 신규 용도 Download PDF

Info

Publication number
KR101817514B1
KR101817514B1 KR1020137003693A KR20137003693A KR101817514B1 KR 101817514 B1 KR101817514 B1 KR 101817514B1 KR 1020137003693 A KR1020137003693 A KR 1020137003693A KR 20137003693 A KR20137003693 A KR 20137003693A KR 101817514 B1 KR101817514 B1 KR 101817514B1
Authority
KR
South Korea
Prior art keywords
weight
hesperetin
composition
skin
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020137003693A
Other languages
English (en)
Korean (ko)
Other versions
KR20130038925A (ko
Inventor
리우 후
홍잉 란
Original Assignee
내처럴 메디슨 인스티튜트 오브 제지앙 양솅탕 컴퍼티 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 내처럴 메디슨 인스티튜트 오브 제지앙 양솅탕 컴퍼티 리미티드 filed Critical 내처럴 메디슨 인스티튜트 오브 제지앙 양솅탕 컴퍼티 리미티드
Publication of KR20130038925A publication Critical patent/KR20130038925A/ko
Application granted granted Critical
Publication of KR101817514B1 publication Critical patent/KR101817514B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
KR1020137003693A 2010-07-20 2011-06-15 헤스페레틴의 신규 용도 Active KR101817514B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201010231389.2 2010-07-20
CN201010231389.2A CN102266320B (zh) 2010-07-20 2010-07-20 橙皮素的新用途
PCT/CN2011/075765 WO2012010022A1 (zh) 2010-07-20 2011-06-15 橙皮素的新用途

Publications (2)

Publication Number Publication Date
KR20130038925A KR20130038925A (ko) 2013-04-18
KR101817514B1 true KR101817514B1 (ko) 2018-01-11

Family

ID=45048905

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020137003693A Active KR101817514B1 (ko) 2010-07-20 2011-06-15 헤스페레틴의 신규 용도

Country Status (6)

Country Link
US (1) US9351952B2 (enExample)
EP (1) EP2596787B1 (enExample)
JP (1) JP5871921B2 (enExample)
KR (1) KR101817514B1 (enExample)
CN (1) CN102266320B (enExample)
WO (1) WO2012010022A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101817187B1 (ko) 2011-11-25 2018-01-10 내처럴 메디슨 인스티튜트 오브 제지앙 양솅탕 컴퍼티 리미티드 네오헤스페리딘의 신규의 용도
CN104188819B (zh) * 2014-09-25 2016-08-03 山西医科大学 一种透明质酸分散的橙皮素纳米爽肤水及其制备方法
JP6842419B2 (ja) 2015-09-02 2021-03-17 株式会社林原 黄ぐすみ低減用皮膚外用剤
CN111888371A (zh) * 2020-08-07 2020-11-06 广东工业大学 一种糖基化橙皮素化合物在制备缓解痛经制品中的应用
CN115053963A (zh) * 2022-06-28 2022-09-16 仙乐健康科技股份有限公司 一种提升体温和促进体表微循环的组合物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0695181A1 (en) * 1993-04-20 1996-02-07 The Procter & Gamble Company Methods of using hesperetin for sebum control and treatment of acne
FR2778663B1 (fr) * 1998-05-15 2001-05-18 Coletica Nouveaux esters de flavonoides,leur utilisation en cosmetique, dermopharmacie, en pharmacie et en agro-alimentaire
JP2001072564A (ja) * 1999-09-08 2001-03-21 Kanebo Ltd くま改善剤
US6607735B2 (en) * 2000-12-21 2003-08-19 Johnson & Johnson Consumer Companies, Inc. Method for reducing the appearance of dark circles under the eyes
MXPA04006039A (es) * 2001-12-19 2004-09-27 The Quigley Corp Metodo para el tratamiento de afecciones vasculares y neuronales perifericas.
FR2834639A1 (fr) * 2002-01-11 2003-07-18 Medix Lab Composition comprenant en association au moins un flavonoide et au moins une huile vegetale, son utilisation comme agent dermatologique ou dermatocosmetique
FR2836042B1 (fr) * 2002-02-15 2004-04-02 Sederma Sa Compositions cosmetiques ou dermopharmaceutiques pour diminuer les poches et cernes sous les yeux
US20080008673A1 (en) * 2006-07-03 2008-01-10 Claudie Willemin Compositions comprising at least one C-glycoside derivative
FR2919501B1 (fr) * 2007-08-02 2010-12-31 Oreal Utilisation d'hesperidine ou de l'un de ses derives pour la prevention et/ou le traitement des peaux relachees
JP5551582B2 (ja) * 2008-03-17 2014-07-16 株式会社林原 皮膚外用剤
WO2009127058A1 (en) 2008-04-15 2009-10-22 Immanence Integrale Dermo Correction Inc. Skin care compositions and methods of use thereof
FR2933608B1 (fr) * 2008-07-11 2014-01-10 Lvmh Rech Nouvelle utilisation d'un extrait de grande mauve agent hydratant, et composition cosmetique le contenant.
JP5203084B2 (ja) 2008-07-30 2013-06-05 江崎グリコ株式会社 分散ヘスペレチン

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Chem. Pharm. Bull. May 2010. Vol. 58, No. 5, pp. 611-614*

Also Published As

Publication number Publication date
JP2013536169A (ja) 2013-09-19
EP2596787A1 (en) 2013-05-29
KR20130038925A (ko) 2013-04-18
EP2596787A4 (en) 2013-12-25
JP5871921B2 (ja) 2016-03-01
CN102266320B (zh) 2015-06-17
HK1162953A1 (zh) 2012-09-07
CN102266320A (zh) 2011-12-07
US20130131160A1 (en) 2013-05-23
EP2596787B1 (en) 2015-11-25
WO2012010022A1 (zh) 2012-01-26
US9351952B2 (en) 2016-05-31

Similar Documents

Publication Publication Date Title
WO2008139182A2 (en) Skin care composition
KR101817514B1 (ko) 헤스페레틴의 신규 용도
CN104434642B (zh) 一种晒后修护美白保湿凝露及其制备方法
CN104188859B (zh) 一种含天然成分提取物的抗皱嫩肤乳液及其制备方法
DE202005007603U1 (de) Zusammensetzung umfassend eine Kombination aus Arganöl und Schwarzkümmelöl
CN104188808B (zh) 一种祛斑祛黄凝胶及其制备方法
CN103816083A (zh) 一种含碱性成纤维细胞生长因子的祛痘除印透明乳液及其制备方法
CN115844784B (zh) 一种用于干燥皮肤舒敏抗炎的组合物及其应用和制备方法
CN112057388A (zh) 一种用于妊娠纹修复的乳霜及其制备方法
CN113995701B (zh) 一种祛痘和消除痘印的组合物及其制备方法和应用
CN111821228A (zh) 一种祛黄抗皮肤光老化的组合物及其应用
KR101817187B1 (ko) 네오헤스페리딘의 신규의 용도
JP6651084B1 (ja) ユズ種子及び玄米の抽出物を含有する組成物
JP5855949B2 (ja) ケラチン産生促進剤、染毛用剤及びマニキュア用剤
CN113274339A (zh) 一种具有止痒保湿功效的硅油乳膏及其制备方法
CN107115383B (zh) 具有防治皮肤干燥综合征功效的皮肤养护/治疗组合物
KR20230143023A (ko) 시지지움 포르모슘 추출물을 유효성분으로 포함하는 피부 개선용 조성물
TWI421098B (zh) New use of new hesperidin
TWI491404B (zh) New use of hesperetin
PL244324B1 (pl) Krem pod oczy typu olej w wodzie
CN117064769A (zh) 一种多靶点祛眼袋组合物及其制备方法和应用
DE202006018519U1 (de) Feuchtigkeitsspendende wasserhaltige Sanddorn-Hautpflegepräparate (Emulsionen)
HK1162953B (zh) 橙皮素的新用途
HK1160777B (en) Novel use of neohesperidoside
HK1160777A1 (en) Novel use of neohesperidoside

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20130213

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20161129

Patent event code: PE09021S01D

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20170628

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20171114

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20180105

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20180108

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20201218

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20211230

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20231219

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20241211

Start annual number: 8

End annual number: 8